Spring direct naar de hoofdnavigatie of de inhoud

Life Sciences sector


Home / Sectors / Life Sciences

Life Sciences

In life sciences, including biotechnology, V.O. represents clients in a broad range of traditional pharmaceutical as well as biological technologies, including immunology, virology, molecular biology, animal and plant genetics, gene therapy, protein chemistry, pharmacology, enzymology, bioinformatics and others. Specific areas of expertise include among others diagnostics, recombinant cytokines, antibody technology, personalized medicine, biomarkers, recombinant antigens and vaccines, and antisense and small RNA technology.

From start-ups to multinationals

Our client base in the life sciences and biotechnology sector ranges from biotech start-ups to multinationals. Working for and with biotech start-ups requires a special approach, as balancing research and commercial development may be complex. The long-term IP strategy, for instance, in which the patent portfolio should be attractive to possible investors and licensees, sometimes seems at odds with the short-term company policy. We know exactly how to provide solutions that are workable and effective.

Renowned experts

Our patent attorneys include renowned experts in biotech and life sciences. Some have worked in the life sciences industry, for instance as researcher. All of them are highly dedicated to their profession, and see it as their mission to help companies to build up a sound and balanced IP portfolio that enables these companies to keep up the good work.

Full-service partner

We provide all IP services: drafting and prosecuting patent applications all over the world. We assist you in defending or attacking patents; in infringement suits and in opposition or invalidity proceedings. Other fields of activity are Freedom To Operate analysis, IP audits and Supplementary Protection Certificates for pharmaceuticals and agrochemicals. Particularly for biotech start-ups we commit ourselves to supporting you throughout the different developmental stages of your company. We help you to integrate IP into your operational management and materialize the knowledge assets of your company.

Contact our experts

Tamara Elmore

  • European Patent Attorney
  • Dutch Patent Attorney
  • United States Patent Agent
  • Senior Associate
More experts


Benelux Firm of the Year Award for V.O.

We did it again! During the annual Managing IP’s EMEA  Awards Dinner of 8 March, the Benelux Firm of the Year Award was presented to V.O.Continue reading

Patents are the most important indicator of a company’s powers of innovation

In 2016, the European Patent Office (EPO) granted a record number of patents. The USA submitted the most applications by far (40,076). Germany is placed second (25,086), while the Netherlands and Belgium occupy seventh (6,889) and twelfth (2,186) place respectively. But what does a patent say about a company’s powers of innovation?Continue reading

Finding a breakthrough against antibiotic resistance

It was less than a year ago when, brimming with enthusiasm, he opted for the uncertainty of a start-up. Chemist Andreas A. Bastian started his business AGILeBiotics on the Zernike campus of the University of Groningen. His aim is to achieve a breakthrough in the fight against antibiotic resistance: ‘We have since developed a technology […]Continue reading


Global ManuChem Strategies 2018

Maritim proArte Hotel Berlin, Friedrichstraße

The calendar event for all chemical manufacturers in Europe After a great event in 2017, the 7th annual Global ManuChem 2018 is coming back as the leading event for manufacturers in the chemical industry. It brings together over 150 production, SCM & engineering leaders who are responsible for process optimization, lean manufacturing and business strategy in their companies. More about this event

IPBC Europe 2018: Harnessing IP value in European companies

Hotel Okura Amsterdam, Ferdinand Bolstraat, Amsterdam, Netherlands

European companies are under greater pressure than ever before to maximise the value of the intellectual property they own. This is happening at a time when Brexit and the creation of the Unified Patent Court regime promise some of the most far-reaching changes to the continent’s IP system for many years. More about this event

Seminar “Innovation box”: the fiscal significance of patents

Engels Conference & Meeting Center, Stationsplein 45, 3013 AK Rotterdam, Netherlands

The "innovationbox" (innovatiebox) is an important fiscal instrument for stimulating innovative business activities. It leads to a lower corporate tax on innovation profits. Since the rules for using the innovation box have changed considerably since 1 January 2017, a prominent role is reserved for patents. More about this event